MDxHealth SA

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: BE0974461940

USD

2.86

-0.33 (-10.34%)

Mar 25

NAS

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Ion Beam Applications SA

MDxHealth SA

Nyxoah SA

Sequana Medical NV

Biocartis Group NV

Why is MDxHealth SA ?

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

Poor long term growth as Net Sales has grown by an annual rate of 50.20% and Operating profit at 6.12% over the last 5 years
Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -2.05

Flat results in Sep 25

INTEREST(HY) At USD 12.17 MM has Grown at 34.16%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 83.54%, its profits have risen by 4%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MDxHealth SA for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

MDxHealth SA

81.01%

2.68

58.53%

S&P 500

13.68%

0.71

19.28%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

50.20%

EBIT Growth (5y)

6.12%

EBIT to Interest (avg)

-2.05

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

1.89

Sales to Capital Employed (avg)

1.22

Tax Ratio

1.36%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

54.42%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

-20.19

EV to EBIT

-15.08

EV to EBITDA

-41.38

EV to Capital Employed

5.66

EV to Sales

2.06

PEG Ratio

Dividend Yield

ROCE (Latest)

-37.50%

ROE (Latest)

Negative BV

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at USD -15.38 MM

RAW MATERIAL COST(Y)

Fallen by -8.99% (YoY

NET SALES(Q)

Highest at USD 27.43 MM

-5What is not working for the Company

INTEREST(HY)

At USD 12.17 MM has Grown at 34.16%

Here's what is working for MDxHealth SA

Net Profit

Higher at USD -15.38 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Net Sales

Highest at USD 27.43 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (USD MM)

Raw Material Cost

Fallen by -8.99% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for MDxHealth SA

Interest

At USD 12.17 MM has Grown at 34.16%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)